Sat, 03/08/2025 - 16:27 |
Eradivir announces Phase 2 human challenge study of EV25 in healthy adults infected with influenza |
Purdue |
Sun, 03/02/2025 - 12:03 |
Questions remain about the safety of most medications during pregnancy |
R Street Institute |
Thu, 02/06/2025 - 19:52 |
Anju Software Wins 2025 SCOPE Best of Show Award for TA Scans Feasibility Flex |
Anju Software |
Mon, 02/03/2025 - 18:52 |
AMAC Supports Indiana Bill Requiring Safety Trials for New Drugs & Devices |
AMAC |
Mon, 01/27/2025 - 11:47 |
WCG Launches ClinSphere Total Enrollment: An All-New Participant Recruitment and Retention SaaS Solution for Clinical Trials |
WCG |
Tue, 08/27/2024 - 18:33 |
Fujitsu tackles drug loss in Japan through ecosystem to accelerate digitalization of clinical trials |
Fujitsu |
Wed, 08/14/2024 - 15:08 |
Federal report illuminates need for disability inclusion in clinical trials |
NCD |
Tue, 08/06/2024 - 01:47 |
WCG Announces the Acquisition of Array, Introducing a Unique, Integrated Clinical Research Training Solution |
WCG |
Wed, 07/31/2024 - 16:27 |
Manitoba Government Takes Steps to Grow Life Sciences Sector |
MFCB |
Mon, 07/15/2024 - 13:33 |
New Report Addresses Trial Scarcity, Mapping Trial Distribution, County Demographics |
CenterWatch |
Thu, 07/11/2024 - 18:10 |
ATLANTA, July 9, 2024 Today the American Cancer Society (ACS) announced a new collaboration with Trial Library, Inc., and the Prostate Cancer Clinical Trials Consortium (PCCTC) to support a national initiative to accelerate the recruitment of Black patie |
American Cancer... |
Thu, 07/11/2024 - 18:09 |
American Cancer Society, Trial Library, and Prostate Cancer Clinical Trials Consortium Collaborate to Support Recruitment of Black Patients for Clinical Trials |
American Cancer... |
Thu, 06/27/2024 - 17:01 |
Quoin Pharmaceuticals Announces International Expansion of Ongoing Clinical Trials for Netherton Syndrome |
VABIO |
Thu, 06/27/2024 - 07:18 |
Patients Receiving Protocol Exceptions to Participate in Targeted Therapy Trial Experienced Similar Outcomes as Eligible Participants |
American Associ... |
Wed, 06/26/2024 - 14:25 |
FDA Guidance Provides New Details on Diversity Action Plans Required for Certain Clinical Studies |
FDA |
Wed, 06/26/2024 - 12:46 |
WCG and MRCT Center Form Task Force to Tackle Ethical Challenges in AI-Based Clinical Research |
WCG |
Mon, 06/17/2024 - 19:57 |
New Publication: An evaluation of novel oncology approvals with a PMR/C for assessing data in racial and ethnic populations underrepresented in premarket clinical trials |
Friends of Canc... |
Fri, 05/17/2024 - 00:51 |
New Bipartisan Legislation Would Make It Easier for Cancer Patients to Participate in Clinical Trials |
ACS CAN |
Thu, 05/09/2024 - 20:45 |
NIH to open long COVID clinical trials to study sleep disturbances, exercise intolerance, and post exertional malaise |
NIH |
Mon, 02/19/2024 - 00:47 |
Anju to Exhibit and Present at EUCROF24: Leveraging Data for Enhanced Site Selection and Feasibility in Clinical Trials |
Anju Software |
Wed, 12/28/2022 - 19:21 |
Meet BioAffinity Technologies: Fly exclusive interview with CEO Maria Zannes |
BioAffinity Tec... |
Wed, 12/21/2022 - 14:38 |
Lexicon Announces Topline Results from Phase 2 Proof-of-Concept Study of LX9211 in Postherpetic Neuralgia |
Lexicon Pharmac... |
Thu, 11/17/2022 - 20:23 |
MSF publishes first clinical trial transparency policy |
Doctors Without... |
Mon, 11/14/2022 - 13:54 |
Lexicon Pharmaceuticals Highlights Oral Presentation of Final Results from the RELIEF-DPN-1 Trial of LX9211 at the 16th Annual Pain Therapeutics Summit |
Lexicon Pharmac... |
Wed, 10/26/2022 - 11:21 |
Hepion Pharmaceuticals Announces Publication of Phase 2a AMBITION Clinical Trial Results |
Hepion Pharmace... |